Therapeutic Peptide Market
1 Introduction to Research & Analysis Reports
1.1 Therapeutic Peptide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Therapeutic Peptide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Therapeutic Peptide Overall Market Size
2.1 Global Therapeutic Peptide Market Size: 2022 VS 2029
2.2 Global Therapeutic Peptide Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Therapeutic Peptide Sales: 2018-2029
3 Company Landscape
3.1 Top Therapeutic Peptide Players in Global Market
3.2 Top Global Therapeutic Peptide Companies Ranked by Revenue
3.3 Global Therapeutic Peptide Revenue by Companies
3.4 Global Therapeutic Peptide Sales by Companies
3.5 Global Therapeutic Peptide Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Therapeutic Peptide Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Therapeutic Peptide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Therapeutic Peptide Players in Global Market
3.8.1 List of Global Tier 1 Therapeutic Peptide Companies
3.8.2 List of Global Tier 2 and Tier 3 Therapeutic Peptide Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Therapeutic Peptide Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injection
4.1.4 Other
4.2 By Type - Global Therapeutic Peptide Revenue & Forecasts
4.2.1 By Type - Global Therapeutic Peptide Revenue, 2018-2023
4.2.2 By Type - Global Therapeutic Peptide Revenue, 2024-2029
4.2.3 By Type - Global Therapeutic Peptide Revenue Market Share, 2018-2029
4.3 By Type - Global Therapeutic Peptide Sales & Forecasts
4.3.1 By Type - Global Therapeutic Peptide Sales, 2018-2023
4.3.2 By Type - Global Therapeutic Peptide Sales, 2024-2029
4.3.3 By Type - Global Therapeutic Peptide Sales Market Share, 2018-2029
4.4 By Type - Global Therapeutic Peptide Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Therapeutic Peptide Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Metabolic Disorders
5.1.4 Central Nervous System
5.1.5 Other
5.2 By Application - Global Therapeutic Peptide Revenue & Forecasts
5.2.1 By Application - Global Therapeutic Peptide Revenue, 2018-2023
5.2.2 By Application - Global Therapeutic Peptide Revenue, 2024-2029
5.2.3 By Application - Global Therapeutic Peptide Revenue Market Share, 2018-2029
5.3 By Application - Global Therapeutic Peptide Sales & Forecasts
5.3.1 By Application - Global Therapeutic Peptide Sales, 2018-2023
5.3.2 By Application - Global Therapeutic Peptide Sales, 2024-2029
5.3.3 By Application - Global Therapeutic Peptide Sales Market Share, 2018-2029
5.4 By Application - Global Therapeutic Peptide Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Therapeutic Peptide Market Size, 2022 & 2029
6.2 By Region - Global Therapeutic Peptide Revenue & Forecasts
6.2.1 By Region - Global Therapeutic Peptide Revenue, 2018-2023
6.2.2 By Region - Global Therapeutic Peptide Revenue, 2024-2029
6.2.3 By Region - Global Therapeutic Peptide Revenue Market Share, 2018-2029
6.3 By Region - Global Therapeutic Peptide Sales & Forecasts
6.3.1 By Region - Global Therapeutic Peptide Sales, 2018-2023
6.3.2 By Region - Global Therapeutic Peptide Sales, 2024-2029
6.3.3 By Region - Global Therapeutic Peptide Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Therapeutic Peptide Revenue, 2018-2029
6.4.2 By Country - North America Therapeutic Peptide Sales, 2018-2029
6.4.3 US Therapeutic Peptide Market Size, 2018-2029
6.4.4 Canada Therapeutic Peptide Market Size, 2018-2029
6.4.5 Mexico Therapeutic Peptide Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Therapeutic Peptide Revenue, 2018-2029
6.5.2 By Country - Europe Therapeutic Peptide Sales, 2018-2029
6.5.3 Germany Therapeutic Peptide Market Size, 2018-2029
6.5.4 France Therapeutic Peptide Market Size, 2018-2029
6.5.5 U.K. Therapeutic Peptide Market Size, 2018-2029
6.5.6 Italy Therapeutic Peptide Market Size, 2018-2029
6.5.7 Russia Therapeutic Peptide Market Size, 2018-2029
6.5.8 Nordic Countries Therapeutic Peptide Market Size, 2018-2029
6.5.9 Benelux Therapeutic Peptide Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Therapeutic Peptide Revenue, 2018-2029
6.6.2 By Region - Asia Therapeutic Peptide Sales, 2018-2029
6.6.3 China Therapeutic Peptide Market Size, 2018-2029
6.6.4 Japan Therapeutic Peptide Market Size, 2018-2029
6.6.5 South Korea Therapeutic Peptide Market Size, 2018-2029
6.6.6 Southeast Asia Therapeutic Peptide Market Size, 2018-2029
6.6.7 India Therapeutic Peptide Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Therapeutic Peptide Revenue, 2018-2029
6.7.2 By Country - South America Therapeutic Peptide Sales, 2018-2029
6.7.3 Brazil Therapeutic Peptide Market Size, 2018-2029
6.7.4 Argentina Therapeutic Peptide Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Therapeutic Peptide Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Therapeutic Peptide Sales, 2018-2029
6.8.3 Turkey Therapeutic Peptide Market Size, 2018-2029
6.8.4 Israel Therapeutic Peptide Market Size, 2018-2029
6.8.5 Saudi Arabia Therapeutic Peptide Market Size, 2018-2029
6.8.6 UAE Therapeutic Peptide Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Therapeutic Peptide Major Product Offerings
7.1.4 AbbVie Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Therapeutic Peptide Major Product Offerings
7.2.4 AstraZeneca Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Ipsen
7.3.1 Ipsen Company Summary
7.3.2 Ipsen Business Overview
7.3.3 Ipsen Therapeutic Peptide Major Product Offerings
7.3.4 Ipsen Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.3.5 Ipsen Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Therapeutic Peptide Major Product Offerings
7.4.4 Eli Lilly Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Therapeutic Peptide Major Product Offerings
7.5.4 Merck Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Novo Nordisk
7.6.1 Novo Nordisk Company Summary
7.6.2 Novo Nordisk Business Overview
7.6.3 Novo Nordisk Therapeutic Peptide Major Product Offerings
7.6.4 Novo Nordisk Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.6.5 Novo Nordisk Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Therapeutic Peptide Major Product Offerings
7.7.4 Novartis Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Company Summary
7.8.2 Johnson and Johnson Business Overview
7.8.3 Johnson and Johnson Therapeutic Peptide Major Product Offerings
7.8.4 Johnson and Johnson Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.8.5 Johnson and Johnson Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Therapeutic Peptide Major Product Offerings
7.9.4 Sanofi Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Teva
7.10.1 Teva Company Summary
7.10.2 Teva Business Overview
7.10.3 Teva Therapeutic Peptide Major Product Offerings
7.10.4 Teva Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.10.5 Teva Key News & Latest Developments
7.11 Takeda
7.11.1 Takeda Company Summary
7.11.2 Takeda Therapeutic Peptide Business Overview
7.11.3 Takeda Therapeutic Peptide Major Product Offerings
7.11.4 Takeda Therapeutic Peptide Sales and Revenue in Global (2018-2023)
7.11.5 Takeda Key News & Latest Developments
8 Global Therapeutic Peptide Production Capacity, Analysis
8.1 Global Therapeutic Peptide Production Capacity, 2018-2029
8.2 Therapeutic Peptide Production Capacity of Key Manufacturers in Global Market
8.3 Global Therapeutic Peptide Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Therapeutic Peptide Supply Chain Analysis
10.1 Therapeutic Peptide Industry Value Chain
10.2 Therapeutic Peptide Upstream Market
10.3 Therapeutic Peptide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Therapeutic Peptide Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Therapeutic Peptide in Global Market
Table 2. Top Therapeutic Peptide Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Therapeutic Peptide Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Therapeutic Peptide Revenue Share by Companies, 2018-2023
Table 5. Global Therapeutic Peptide Sales by Companies, (K Units), 2018-2023
Table 6. Global Therapeutic Peptide Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Therapeutic Peptide Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Therapeutic Peptide Product Type
Table 9. List of Global Tier 1 Therapeutic Peptide Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Therapeutic Peptide Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Therapeutic Peptide Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Therapeutic Peptide Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Therapeutic Peptide Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Therapeutic Peptide Sales (K Units), 2018-2023
Table 15. By Type - Global Therapeutic Peptide Sales (K Units), 2024-2029
Table 16. By Application ? Global Therapeutic Peptide Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Therapeutic Peptide Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Therapeutic Peptide Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Therapeutic Peptide Sales (K Units), 2018-2023
Table 20. By Application - Global Therapeutic Peptide Sales (K Units), 2024-2029
Table 21. By Region ? Global Therapeutic Peptide Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Therapeutic Peptide Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Therapeutic Peptide Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Therapeutic Peptide Sales (K Units), 2018-2023
Table 25. By Region - Global Therapeutic Peptide Sales (K Units), 2024-2029
Table 26. By Country - North America Therapeutic Peptide Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Therapeutic Peptide Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Therapeutic Peptide Sales, (K Units), 2018-2023
Table 29. By Country - North America Therapeutic Peptide Sales, (K Units), 2024-2029
Table 30. By Country - Europe Therapeutic Peptide Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Therapeutic Peptide Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Therapeutic Peptide Sales, (K Units), 2018-2023
Table 33. By Country - Europe Therapeutic Peptide Sales, (K Units), 2024-2029
Table 34. By Region - Asia Therapeutic Peptide Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Therapeutic Peptide Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Therapeutic Peptide Sales, (K Units), 2018-2023
Table 37. By Region - Asia Therapeutic Peptide Sales, (K Units), 2024-2029
Table 38. By Country - South America Therapeutic Peptide Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Therapeutic Peptide Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Therapeutic Peptide Sales, (K Units), 2018-2023
Table 41. By Country - South America Therapeutic Peptide Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Therapeutic Peptide Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Therapeutic Peptide Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Therapeutic Peptide Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Therapeutic Peptide Sales, (K Units), 2024-2029
Table 46. AbbVie Company Summary
Table 47. AbbVie Therapeutic Peptide Product Offerings
Table 48. AbbVie Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Therapeutic Peptide Product Offerings
Table 52. AstraZeneca Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Ipsen Company Summary
Table 55. Ipsen Therapeutic Peptide Product Offerings
Table 56. Ipsen Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Ipsen Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Therapeutic Peptide Product Offerings
Table 60. Eli Lilly Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Therapeutic Peptide Product Offerings
Table 64. Merck Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Novo Nordisk Company Summary
Table 67. Novo Nordisk Therapeutic Peptide Product Offerings
Table 68. Novo Nordisk Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Novo Nordisk Key News & Latest Developments
Table 70. Novartis Company Summary
Table 71. Novartis Therapeutic Peptide Product Offerings
Table 72. Novartis Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Novartis Key News & Latest Developments
Table 74. Johnson and Johnson Company Summary
Table 75. Johnson and Johnson Therapeutic Peptide Product Offerings
Table 76. Johnson and Johnson Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Johnson and Johnson Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Therapeutic Peptide Product Offerings
Table 80. Sanofi Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Sanofi Key News & Latest Developments
Table 82. Teva Company Summary
Table 83. Teva Therapeutic Peptide Product Offerings
Table 84. Teva Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Teva Key News & Latest Developments
Table 86. Takeda Company Summary
Table 87. Takeda Therapeutic Peptide Product Offerings
Table 88. Takeda Therapeutic Peptide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Takeda Key News & Latest Developments
Table 90. Therapeutic Peptide Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Therapeutic Peptide Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Therapeutic Peptide Production by Region, 2018-2023 (K Units)
Table 93. Global Therapeutic Peptide Production by Region, 2024-2029 (K Units)
Table 94. Therapeutic Peptide Market Opportunities & Trends in Global Market
Table 95. Therapeutic Peptide Market Drivers in Global Market
Table 96. Therapeutic Peptide Market Restraints in Global Market
Table 97. Therapeutic Peptide Raw Materials
Table 98. Therapeutic Peptide Raw Materials Suppliers in Global Market
Table 99. Typical Therapeutic Peptide Downstream
Table 100. Therapeutic Peptide Downstream Clients in Global Market
Table 101. Therapeutic Peptide Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Therapeutic Peptide Segment by Type in 2022
Figure 2. Therapeutic Peptide Segment by Application in 2022
Figure 3. Global Therapeutic Peptide Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Therapeutic Peptide Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Therapeutic Peptide Revenue, 2018-2029 (US$, Mn)
Figure 7. Therapeutic Peptide Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Therapeutic Peptide Revenue in 2022
Figure 9. By Type - Global Therapeutic Peptide Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Therapeutic Peptide Revenue Market Share, 2018-2029
Figure 11. By Type - Global Therapeutic Peptide Sales Market Share, 2018-2029
Figure 12. By Type - Global Therapeutic Peptide Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Therapeutic Peptide Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Therapeutic Peptide Revenue Market Share, 2018-2029
Figure 15. By Application - Global Therapeutic Peptide Sales Market Share, 2018-2029
Figure 16. By Application - Global Therapeutic Peptide Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Therapeutic Peptide Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Therapeutic Peptide Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Therapeutic Peptide Revenue Market Share, 2018-2029
Figure 20. By Region - Global Therapeutic Peptide Sales Market Share, 2018-2029
Figure 21. By Country - North America Therapeutic Peptide Revenue Market Share, 2018-2029
Figure 22. By Country - North America Therapeutic Peptide Sales Market Share, 2018-2029
Figure 23. US Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Therapeutic Peptide Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Therapeutic Peptide Sales Market Share, 2018-2029
Figure 28. Germany Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 29. France Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Therapeutic Peptide Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Therapeutic Peptide Sales Market Share, 2018-2029
Figure 37. China Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 41. India Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Therapeutic Peptide Revenue Market Share, 2018-2029
Figure 43. By Country - South America Therapeutic Peptide Sales Market Share, 2018-2029
Figure 44. Brazil Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Therapeutic Peptide Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Therapeutic Peptide Sales Market Share, 2018-2029
Figure 48. Turkey Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Therapeutic Peptide Revenue, (US$, Mn), 2018-2029
Figure 52. Global Therapeutic Peptide Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Therapeutic Peptide by Region, 2022 VS 2029
Figure 54. Therapeutic Peptide Industry Value Chain
Figure 55. Marketing Channels